Medical Net, Inc. (TYO:3645)
Japan
· Delayed Price · Currency is JPY 305.00
+1.00 (0.33%)
Apr 30, 2026, 9:01 AM JST
Medical Net Income Statement
Financials in millions JPY. Fiscal year is June - May.
Millions JPY. Fiscal year is Jun - May.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Feb '26 Feb 28, 2026 | May '25 May 31, 2025 | May '24 May 31, 2024 | May '23 May 31, 2023 | May '22 May 31, 2022 | May '21 May 31, 2021 | 2020 - 2016 |
| Revenue | 6,606 | 6,077 | 5,252 | 4,500 | 3,745 | 3,330 | Upgrade
|
| Revenue Growth (YoY) | 9.77% | 15.71% | 16.71% | 20.16% | 12.46% | 14.16% | Upgrade
|
| Cost of Revenue | 4,622 | 4,112 | 3,411 | 2,720 | 2,285 | 2,153 | Upgrade
|
| Gross Profit | 1,984 | 1,965 | 1,841 | 1,780 | 1,460 | 1,177 | Upgrade
|
| Selling, General & Admin | 1,821 | 1,864 | 1,524 | 1,396 | 1,000 | 845 | Upgrade
|
| Operating Expenses | 1,824 | 1,866 | 1,542 | 1,401 | 1,010 | 846 | Upgrade
|
| Operating Income | 160 | 99 | 299 | 379 | 450 | 331 | Upgrade
|
| Interest Expense | -13 | -11 | -6 | -3 | -1 | -1 | Upgrade
|
| Interest & Investment Income | 6 | 3 | 1 | - | - | - | Upgrade
|
| Currency Exchange Gain (Loss) | 112 | 25 | 34 | 45 | 8 | 2 | Upgrade
|
| Other Non Operating Income (Expenses) | 3 | 18 | -7 | 10 | -5 | 3 | Upgrade
|
| EBT Excluding Unusual Items | 268 | 134 | 321 | 431 | 452 | 335 | Upgrade
|
| Gain (Loss) on Sale of Investments | 352 | 352 | -4 | -40 | 84 | -81 | Upgrade
|
| Gain (Loss) on Sale of Assets | 1 | - | 5 | 2 | - | - | Upgrade
|
| Asset Writedown | -22 | -154 | -170 | -143 | - | - | Upgrade
|
| Other Unusual Items | -301 | -308 | -1 | - | - | -1 | Upgrade
|
| Pretax Income | 298 | 24 | 151 | 250 | 536 | 253 | Upgrade
|
| Income Tax Expense | 71 | 62 | 126 | 141 | 137 | 116 | Upgrade
|
| Earnings From Continuing Operations | 227 | -38 | 25 | 109 | 399 | 137 | Upgrade
|
| Minority Interest in Earnings | -25 | -30 | -20 | 7 | -15 | -8 | Upgrade
|
| Net Income | 202 | -68 | 5 | 116 | 384 | 129 | Upgrade
|
| Net Income to Common | 202 | -68 | 5 | 116 | 384 | 129 | Upgrade
|
| Net Income Growth | - | - | -95.69% | -69.79% | 197.67% | 63.29% | Upgrade
|
| Shares Outstanding (Basic) | 9 | 9 | 9 | 9 | 9 | 8 | Upgrade
|
| Shares Outstanding (Diluted) | 9 | 9 | 9 | 9 | 9 | 8 | Upgrade
|
| Shares Change (YoY) | 0.67% | -1.34% | 0.94% | 2.40% | 3.65% | -1.53% | Upgrade
|
| EPS (Basic) | 22.29 | -7.62 | 0.55 | 12.95 | 43.88 | 15.28 | Upgrade
|
| EPS (Diluted) | 22.29 | -7.62 | 0.55 | 12.95 | 43.88 | 15.28 | Upgrade
|
| EPS Growth | - | - | -95.73% | -70.50% | 187.19% | 65.83% | Upgrade
|
| Free Cash Flow | - | -211 | 87 | 410 | 340 | 378 | Upgrade
|
| Free Cash Flow Per Share | - | -23.64 | 9.62 | 45.76 | 38.85 | 44.77 | Upgrade
|
| Dividend Per Share | 3.000 | 3.000 | 3.000 | 2.500 | 2.500 | 2.500 | Upgrade
|
| Dividend Growth | - | - | 20.00% | - | - | 233.33% | Upgrade
|
| Gross Margin | 30.03% | 32.34% | 35.05% | 39.56% | 38.98% | 35.34% | Upgrade
|
| Operating Margin | 2.42% | 1.63% | 5.69% | 8.42% | 12.02% | 9.94% | Upgrade
|
| Profit Margin | 3.06% | -1.12% | 0.10% | 2.58% | 10.25% | 3.87% | Upgrade
|
| Free Cash Flow Margin | - | -3.47% | 1.66% | 9.11% | 9.08% | 11.35% | Upgrade
|
| EBITDA | 253.25 | 175 | 352 | 440 | 479 | 355 | Upgrade
|
| EBITDA Margin | 3.83% | 2.88% | 6.70% | 9.78% | 12.79% | 10.66% | Upgrade
|
| D&A For EBITDA | 93.25 | 76 | 53 | 61 | 29 | 24 | Upgrade
|
| EBIT | 160 | 99 | 299 | 379 | 450 | 331 | Upgrade
|
| EBIT Margin | 2.42% | 1.63% | 5.69% | 8.42% | 12.02% | 9.94% | Upgrade
|
| Effective Tax Rate | 23.83% | 258.33% | 83.44% | 56.40% | 25.56% | 45.85% | Upgrade
|
| Advertising Expenses | - | 154 | 119 | 119 | 108 | 72 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.